this is great news. dilution inevitable but am glad they are proceeding with this trial. I am back in
- Forums
- ASX - By Stock
- 1AI
- Ann: Secures Funds for 3rd Trial of NTCELL in Parkinson Disease
Ann: Secures Funds for 3rd Trial of NTCELL in Parkinson Disease, page-12
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $13.90K | 1.986M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 3764983 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 41489 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 3764983 | 0.006 |
11 | 3916885 | 0.005 |
6 | 4095009 | 0.004 |
3 | 3800000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 41489 | 1 |
0.008 | 1901847 | 6 |
0.009 | 3869315 | 9 |
0.010 | 2413365 | 3 |
0.011 | 836153 | 2 |
Last trade - 10.57am 15/11/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online